Myasthenia gravis presents as a chronic autoimmune disease. In this situation, the body's immune defense mechanism mistakenly strikes the nerve cells that control voluntary contractions. This interference leads to debility, which intensifies with use and strengthens with recuperation. Symptoms can vary widely from person to person, but common sign

Famotidine serves as a histamine H2-receptor antagonist, effectively inhibiting the release of gastric acid. This action alleviates the symptoms of various gastrointestinal disorders, comprising peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Famotidine's mechanistic profile demonstrates a relatively long half